Analysts expect Dare Bioscience, Inc. to report revenue of 2.15 M for Q3 26, against a range of 1.94 M to 2.36 M. The most recent reported quarter, Q2 26, came in at 187,550.00 , in line with the 1,574.94 consensus.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 22,440.00 | 41,690.00 | 25,430.00 | -21,170.00 | 2,260.00 | 1.02 M | 152,460.00 | 187,550.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 8.16 M | 1.18 M | 676,279.21 | 313,801.11 | 14,177.55 | 876,609.89 | 28,914.78 | 1,704.40 | 2.36 M | 438,959.76 | 1.26 M | 1.73 M | 2.96 M | 1.59 M | 3.85 M | 5.06 M | ||||||||||
| Low Estimate | 7.10 M | 975,486.39 | 594,112.79 | 276,377.31 | 12,951.59 | 724,490.91 | 26,207.34 | 1,445.48 | 1.94 M | 362,597.04 | 1.11 M | 1.56 M | 2.46 M | 1.32 M | 3.28 M | 4.29 M | ||||||||||
| Consensus Estimate | 7.63 M | 1.08 M | 635,196.00 | 295,089.21 | 13,564.57 | 800,550.40 | 27,561.06 | 1,574.94 | 2.15 M | 400,778.40 | 1.18 M | 1.64 M | 2.71 M | 1.46 M | 3.57 M | 4.67 M |
Analysts expect Dare Bioscience, Inc. to report earnings per share of -0.12 for Q3 26, against a range of -0.12 to -0.12. The most recent reported quarter, Q2 26, came in at -0.20, a 28.6% beat against the -0.28 consensus.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.52 | -0.55 | -0.50 | -0.45 | -0.28 | 0.03 | -0.20 | -0.20 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.04 | -0.63 | -0.55 | -0.53 | -0.33 | -0.41 | -0.28 | -0.27 | -0.12 | -0.20 | -0.11 | -0.12 | -0.27 | -0.22 | 0.09 | 0.01 | ||||||||||
| Low Estimate | -0.04 | -0.69 | -0.67 | -0.61 | -0.39 | -0.45 | -0.30 | -0.29 | -0.12 | -0.22 | -0.13 | -0.14 | -0.31 | -0.24 | 0.09 | 0.01 | ||||||||||
| Consensus Estimate | -0.04 | -0.66 | -0.61 | -0.57 | -0.36 | -0.43 | -0.29 | -0.28 | -0.12 | -0.21 | -0.12 | -0.13 | -0.29 | -0.23 | 0.09 | 0.01 |
Pull Wall Street consensus for Dare Bioscience, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=DARE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "DARE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=DARE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();